Literature DB >> 1833016

Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow.

R L Truitt1, A A Atasoylu.   

Abstract

A murine model of allogeneic bone marrow (BM) transplantation was used to determine the relative importance of CD4+ and CD8+ T cells in establishing donor T cell chimerism and in the development of graft-versus-host (GVH) and graft-versus-leukemia (GVL) reactivity. Mature donor T cells were essential for complete chimerism when host mice (AKR, H-2k) were conditioned with suboptimal irradiation (9 Gy = LD50). Transplantation of donor BM (B10.BR, H-2k) resulted in mixed chimerism, whereas mice given BM containing additional T cells developed into complete and stable chimeras. Depletion of T cell subsets was associated with an increase in the frequency of mixed chimerism. The incidence of lethal GVHD was dependent on the number of T cells added to the BM inoculum. Ex vivo depletion of CD4+ T cells eliminated GVH-associated mortality. Removal of CD8+ T cells had no effect on overall survival. In contrast to the GVH results, removal of either CD4+ or CD8+ T cells compromised GVL reactivity, indicating that an optimal GVL response required both CD4+ and CD8+ T cells. T cell-subset depletion did not interfere with the induction of donor-host tolerance in these chimeras and may have facilitated its development. The loss of GVH/GVL effector cells as a result of T cell depletion and the development of donor-host tolerance may act synergistically to prevent or suppress GVH and GVL reactivity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1833016

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  18 in total

Review 1.  Leukodystrophy and bone marrow transplantation: role of mixed hematopoietic chimerism.

Authors:  C L Kaufman; S T Ildstad
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

2.  The clinical implications of mixed lymphocyte reaction with leukemic cells.

Authors:  Hee-Je Kim; Tai-Gyu Kim; Hyun Il Cho; Hoon Han; Woo-Sung Min; Chun-Choo Kim
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

Review 3.  Naturally acquired microchimerism: implications for transplantation outcome and novel methodologies for detection.

Authors:  Michael Eikmans; Astrid G S van Halteren; Koen van Besien; Jon J van Rood; Jos J M Drabbels; Frans H J Claas
Journal:  Chimerism       Date:  2014

4.  Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity.

Authors:  Martin Vaeth; Carina A Bäuerlein; Tobias Pusch; Janina Findeis; Martin Chopra; Anja Mottok; Andreas Rosenwald; Andreas Beilhack; Friederike Berberich-Siebelt
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-12       Impact factor: 11.205

5.  Using immuno-PET imaging to monitor kinetics of T cell-mediated inflammation and treatment efficiency in a humanized mouse model for GvHD.

Authors:  Stefanie Pektor; Janine Schlöder; Benedikt Klasen; Nicole Bausbacher; Daniel-Christoph Wagner; Mathias Schreckenberger; Stephan Grabbe; Helmut Jonuleit; Matthias Miederer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-31       Impact factor: 9.236

6.  Vitamin C stabilizes CD8+ iTregs and enhances their therapeutic potential in controlling murine GVHD and leukemia relapse.

Authors:  Supinya Iamsawat; Linlu Tian; Anusara Daenthanasanmak; Yongxia Wu; Hung D Nguyen; David Bastian; Xue-Zhong Yu
Journal:  Blood Adv       Date:  2019-12-23

Review 7.  Current thoughts on the pathogenesis of graft versus host disease.

Authors:  A L Appleton; L Sviland
Journal:  J Clin Pathol       Date:  1993-09       Impact factor: 3.411

8.  Diagnostic features of transfusion associated graft versus host disease.

Authors:  A L Appleton; L Sviland; A D Pearson; J Wilkes; M A Green; A J Malcolm
Journal:  J Clin Pathol       Date:  1994-06       Impact factor: 3.411

9.  Control of graft-versus-host disease with maintenance of the graft-versus-leukemia effect in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes.

Authors:  Steven M Kornblau; Preston G Aycox; Clifton Stephens; L David McCue; Richard E Champlin; Frank C Marini
Journal:  Exp Hematol       Date:  2007-05       Impact factor: 3.084

Review 10.  Graft-versus-host disease after donor leukocyte infusions: presentation and management.

Authors:  Noelle V Frey; David L Porter
Journal:  Best Pract Res Clin Haematol       Date:  2008-06       Impact factor: 3.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.